![Gregory Ciongoli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory Ciongoli
Presidente presso
ATARA BIOTHERAPEUTICS, INC.
Patrimonio netto: 14 M $ in data 30/09/2026
Profilo
Mr. Gregory A. Ciongoli is an Independent Director at Gossamer Bio, Inc., an Independent Director at REGENXBIO, Inc., a Chairman at Atara Biotherapeutics, Inc. and a Managing Partner at Adiumentum Capital Management LLC.
He is on the Board of Directors at Gossamer Bio, Inc., REGENXBIO, Inc. and Zymeworks, Inc. Mr. Ciongoli was previously employed as a Partner by The Baupost Group LLC.
He received his undergraduate degree from Woodrow Wilson School of Public & International Affairs and an MBA from Harvard Business School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ZYMEWORKS INC. 0,7% | 12/01/2026 | 493.500 ( 0,7% ) | 13 M $ | 30/09/2026 |
REGENXBIO, INC. 0,18% | 27/08/2026 | 118.035 ( 0,18% ) | 888 804 $ | 30/09/2026 |
| 09/06/2026 | 12.000 ( 0,12% ) | 102 000 $ | 30/09/2026 | |
GOSSAMER BIO, INC. -.--% | 23/09/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
Posizioni attive di Gregory Ciongoli
| Società | Posizione | Inizio |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Presidente | 03/09/2025 |
| ZYMEWORKS INC. | Direttore/Membro del Consiglio | 11/08/2025 |
| REGENXBIO INC. | Direttore/Membro del Consiglio | 25/08/2026 |
| GOSSAMER BIO, INC. | Direttore/Membro del Consiglio | 16/09/2026 |
Precedenti posizioni note di Gregory Ciongoli
| Società | Posizione | Fine |
|---|---|---|
The Baupost Group LLC
 The Baupost Group LLC Investment ManagersFinance Baupost is an opportunistic, value-oriented, open mandate investor that seeks to invest their capital to achieve attractive risk-adjusted returns over an extended period of time. The firm seeks to invest in assets which are undervalued relative to their market price. | Corporate Officer/Principal | - |
Formazione di Gregory Ciongoli
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
51
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
The Baupost Group LLC
The Baupost Group LLC Investment ManagersFinance Baupost is an opportunistic, value-oriented, open mandate investor that seeks to invest their capital to achieve attractive risk-adjusted returns over an extended period of time. The firm seeks to invest in assets which are undervalued relative to their market price. | Finance |
REGENXBIO, Inc.
 REGENXBIO, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Woodrow Wilson School of Public & International Affairs
 Woodrow Wilson School of Public & International Affairs Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gossamer Bio, Inc.
 Gossamer Bio, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing therapeutics for immunology, inflammation and oncology diseases | Health Technology |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
